SK Biopharmaceuticals Co Ltd
KRX:326030

Watchlist Manager
SK Biopharmaceuticals Co Ltd Logo
SK Biopharmaceuticals Co Ltd
KRX:326030
Watchlist
Price: 102 400 KRW -1.54%
Market Cap: 8T KRW
Have any thoughts about
SK Biopharmaceuticals Co Ltd?
Write Note

SK Biopharmaceuticals Co Ltd
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SK Biopharmaceuticals Co Ltd
PP&E Net Peer Comparison

Comparables:
000100
008930
128940
S
000250
C
068760

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
SK Biopharmaceuticals Co Ltd
KRX:326030
PP&E Net
â‚©47.8B
CAGR 3-Years
25%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
PP&E Net
â‚©543.1B
CAGR 3-Years
18%
CAGR 5-Years
10%
CAGR 10-Years
9%
Hanmi Science Co Ltd
KRX:008930
PP&E Net
â‚©96.4B
CAGR 3-Years
57%
CAGR 5-Years
31%
CAGR 10-Years
17%
Hanmi Pharm Co Ltd
KRX:128940
PP&E Net
â‚©841.9B
CAGR 3-Years
-5%
CAGR 5-Years
-2%
CAGR 10-Years
12%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
PP&E Net
â‚©87.6B
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
6%
C
Celltrion Pharm Inc
KOSDAQ:068760
PP&E Net
â‚©212.5B
CAGR 3-Years
-5%
CAGR 5-Years
1%
CAGR 10-Years
3%

See Also

What is SK Biopharmaceuticals Co Ltd's PP&E Net?
PP&E Net
47.8B KRW

Based on the financial report for Dec 31, 2023, SK Biopharmaceuticals Co Ltd's PP&E Net amounts to 47.8B KRW.

What is SK Biopharmaceuticals Co Ltd's PP&E Net growth rate?
PP&E Net CAGR 5Y
31%

Over the last year, the PP&E Net growth was 135%. The average annual PP&E Net growth rates for SK Biopharmaceuticals Co Ltd have been 25% over the past three years , 31% over the past five years .

Back to Top